Versor Investments’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Buy |
+19,000
| New | +$600K | 0.11% | 325 |
|
|
2024
Q4 | – | Sell |
-14,284
| Closed | -$571K | – | 853 |
|
|
2024
Q3 | $571K | Sell |
14,284
-3,926
| -22% | -$157K | 0.09% | 371 |
|
|
2024
Q2 | $549K | Buy |
+18,210
| New | +$549K | 0.1% | 328 |
|
|
2024
Q1 | – | Sell |
-10,661
| Closed | -$344K | – | 776 |
|
|
2023
Q4 | $344K | Buy |
10,661
+2,850
| +36% | +$92.1K | 0.07% | 478 |
|
|
2023
Q3 | $256K | Buy |
7,811
+871
| +13% | +$28.5K | 0.05% | 527 |
|
|
2023
Q2 | $244K | Sell |
6,940
-2,509
| -27% | -$88.3K | 0.04% | 496 |
|
|
2023
Q1 | $309K | Buy |
9,449
+4,599
| +95% | +$150K | 0.04% | 486 |
|
|
2022
Q4 | $267K | Buy |
+4,850
| New | +$267K | 0.02% | 552 |
|